Cornerstone Planning Group LLC Aurinia Pharmaceuticals Inc. Transaction History
Cornerstone Planning Group LLC
- $378 Billion
- Q3 2024
A detailed history of Cornerstone Planning Group LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 780 shares of AUPH stock, worth $7,098. This represents 0.0% of its overall portfolio holdings.
Number of Shares
780
Previous 780
-0.0%
Holding current value
$7,098
Previous $4.19 Million
39.46%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AUPH
# of Institutions
208Shares Held
58.6MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$84.4 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$74.6 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$65.8 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$36.1 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$26.8 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.29B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...